ストックスクリーナーアプリを入手
12.76
2.08%
0.23
Regenxbio Inc (RGNX) 最新ニュース
A closer look at Regenxbio Inc (RGNX) is warranted - US Post News
Stock Surge: Regenxbio Inc (RGNX) Closes at 12.53, Marking a -3.24 Increase/Decrease - The Dwinnex
Acadian Asset Management LLC Invests $494,000 in REGENXBIO Inc. (NASDAQ:RGNX) - Defense World
REGENXBIO (NASDAQ:RGNX) Shares Down 3.1% - Defense World
Potential Price Increase for Regenxbio Inc (RGNX) After Recent Insider Activity - Knox Daily
REGENXBIO names Mitchell Chan as new CFO amid growth phase - Investing.com
RegenXBio Appoints New EVP and CFO Amidst Key Developments - TipRanks
REGENXBIO names Mitchell Chan as new CFO amid growth phase By Investing.com - Investing.com Australia
Regenxbio Appoints Chief Financial Officer - Contract Pharma
REGENXBIO Appoints Mitchell Chan as Chief Financial Officer - citybiz
REGENXBIO names Mitchell Chan as new CFO amid growth phase By Investing.com - Investing.com UK
REGENXBIO Appoints Mitchell Chan as Chief Financial Officer - Longview News-Journal
REGENXBIO (NASDAQ:RGNX) Rating Lowered to Sell at StockNews.com - Defense World
Quest Partners LLC Has $491,000 Stock Position in REGENXBIO Inc. (NASDAQ:RGNX) - MarketBeat
REGENXBIO (NASDAQ:RGNX) Shares Down 3.7% - MarketBeat
Does REGENXBIO (NASDAQ:RGNX) Have A Healthy Balance Sheet? - Simply Wall St
REGENXBIO Inc. (NASDAQ:RGNX) Shares Acquired by Principal Financial Group Inc. - Defense World
(RGNX) Trading Report - Stock Traders Daily
Trading Day Review: Regenxbio Inc (RGNX) Gains Momentum, Closing at 11.38 - The Dwinnex
Regenxbio shares keep Buy rating, price target on trial data - Investing.com
Regenxbio shares keep Buy rating, price target on trial data - Investing.com India
Regenxbio shares keep Buy rating, price target on trial data By Investing.com - Investing.com Canada
REGENXBIO’s (RGNX) Buy Rating Reaffirmed at HC Wainwright - Defense World
REGENXBIO Inc. (NASDAQ:RGNX) Director Sells $115,600.00 in Stock - MarketBeat
Assessing Regenxbio: Insights From 5 Financial Analysts - Benzinga
HC Wainwright Reiterates "Buy" Rating for REGENXBIO (NASDAQ:RGNX) - MarketBeat
REGENXBIO (NASDAQ:RGNX) Trading Down 8.5% - MarketBeat
RegenxBio touts positive data for rare disease drug RGX-121 - Clinical Trials Arena
RegenxBio touts positive data for rare disease drug RGX-121 - Yahoo Finance
RegenxBio touts positive data for rare disease drug RGX-121 - Pharmaceutical Technology
REGENXBIO Announces Positive Data from Pivotal Dose Level of RGX-121 Demonstrating Long-Term Systemic Effect - StockTitan
REGENXBIO Inc. (NASDAQ:RGNX) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
REGENXBIO to Participate in Upcoming Investor Conferences - Winchester Herald Chronicle
Louisiana State Employees Retirement System Raises Position in REGENXBIO Inc. (NASDAQ:RGNX) - Defense World
Panagora Asset Management Inc. Lowers Stake in REGENXBIO Inc. (NASDAQ:RGNX) - MarketBeat
Gene Therapy Market Size to Reach USD 54.39 Billion By 2032 with CAGR of 23.12%, Boosted by Rising Genetic Disorders and Advances in CRISPR Technology - GlobeNewswire Inc.
REGENXBIO to Participate in Upcoming Investor Conferences - StockTitan
REGENXBIO to Participate in Upcoming Investor Conferences - Yahoo Finance
REGENXBIO (NASDAQ:RGNX) Stock Crosses Below 50-Day Moving Average of $12.32 - MarketBeat
REGENXBIO Announces Presentation at the Society for the Study of Inborn Errors of Metabolism (SSIEM) 2024 Annual Symposium - StockTitan
Opinion: Ruling in REGENXBIO-Sarepta Patent Case Threatens Gene Therapy Market - BioSpace
REGENXBIO to Host Conference Call on May 8 to Discuss First Quarter 2024 Financial Results and Recent Operational Highlights - Longview News-Journal
Assenagon Asset Management S.A. Buys 588,773 Shares of REGENXBIO Inc. (NASDAQ:RGNX) - MarketBeat
Analyzing REGENXBIO (NASDAQ:RGNX) and Moderna (NASDAQ:MRNA) - Defense World
Comerica Bank Has $312,000 Position in REGENXBIO Inc. (NASDAQ:RGNX) - Defense World
REGENXBIO to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference - Longview News-Journal
REGENXBIO Inc. (NASDAQ:RGNX) Shares Acquired by Price T Rowe Associates Inc. MD - Defense World
REGENXBIO to Participate in Chardan's 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit - Longview News-Journal
REGENXBIO releases new data on DMD drug ahead of earnings - MSN
Harbor Capital Advisors Inc. Lowers Stock Position in REGENXBIO Inc. (NASDAQ:RGNX) - Defense World
Harbor Capital Advisors Inc. Sells 30,303 Shares of REGENXBIO Inc. (NASDAQ:RGNX) - American Banking and Market News
REGENXBIO Inc. (NASDAQ:RGNX) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
REGENXBIO Inc. (NASDAQ:RGNX) Given Average Rating of “Moderate Buy” by Brokerages - Defense World
REGENXBIO to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference - Citizentribune
REGENXBIO to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference - Longview News-Journal
Phase 1/2 update ‘encouraging’ for DMD gene therapy RGX-202 - Muscular Dystrophy News
FY2024 Earnings Forecast for REGENXBIO Inc. Issued By HC Wainwright (NASDAQ:RGNX) - MarketBeat
It is Poised to be a Bull Market for Regenxbio Inc (RGNX) - SETE News
REGENXBIO Inc. to Post FY2024 Earnings of ($4.99) Per Share, HC Wainwright Forecasts (NASDAQ:RGNX) - Defense World
REGENXBIO Inc. (NASDAQ:RGNX) Shares Sold by Public Employees Retirement System of Ohio - Defense World
REGENXBIO Inc. (NASDAQ:RGNX) Shares Sold by Public Employees Retirement System of Ohio - MarketBeat
REGENXBIO Inc. (NASDAQ:RGNX) Shares Sold by Lazard Asset Management LLC - Defense World
Regenxbio Inc (RGNX) rating initates by Goldman - Knox Daily
1.07%
2.16%
大文字化:
|
ボリューム (24 時間):